1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hypertrophic Scars Global Clinical Trials Review, H1, 2014

Hypertrophic Scars Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 73 pages

Hypertrophic Scars Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Hypertrophic Scars Global Clinical Trials Review, H1, 2014" provides data on the Hypertrophic Scars clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertrophic Scars. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypertrophic Scars. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hypertrophic Scars Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hypertrophic Scars 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypertrophic Scars to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypertrophic Scars to Dermatology Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Hypertrophic Scars 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hypertrophic Scars Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Hypertrophic Scars 30
Dec 04, 2013: RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period 30
Nov 13, 2013: RXi Pharmaceuticals Announces the Start of Their First Phase 2 Study with RXI-109 for Treatment of Hypertrophic Scars in Conjunction with Scar Revision Surgery 30
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Galena Biopharma, Inc. 32
Clinical Trial Overview of Galena Biopharma, Inc. 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Nippon Medical Research, Inc. 34
Clinical Trial Overview of Nippon Medical Research, Inc. 34
MS Clinical Research Pvt Ltd 35
Clinical Trial Overview of MS Clinical Research Pvt Ltd 35
CATALYSIS, S.L. 36
Clinical Trial Overview of CATALYSIS, S.L. 36
Clinical Trial Overview of Top Institutes / Government 37
Mahidol University 37
Clinical Trial Overview of Mahidol University 37
Shiraz University of Medical Sciences 38
Clinical Trial Overview of Shiraz University of Medical Sciences 38
University of Schleswig-Holstein 39
Clinical Trial Overview of University of Schleswig-Holstein 39
University of Alberta 40
Clinical Trial Overview of University of Alberta 40
VU University Medical Center 41
Clinical Trial Overview of VU University Medical Center 41
Samsung Medical Center 42
Clinical Trial Overview of Samsung Medical Center 42
National Taiwan University Hospital 43
Clinical Trial Overview of National Taiwan University Hospital 43
Association of Dutch Burn Centres 44
Clinical Trial Overview of Association of Dutch Burn Centres 44
University of Miami 45
Clinical Trial Overview of University of Miami 45
University of Pittsburgh 46
Clinical Trial Overview of University of Pittsburgh 46
Five Key Clinical Profiles 47
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hypertrophic Scars Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypertrophic Scars Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypertrophic Scars Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hypertrophic Scars Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hypertrophic Scars Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hypertrophic Scars Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hypertrophic Scars Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hypertrophic Scars to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Hypertrophic Scars Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypertrophic Scars Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypertrophic Scars to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Hypertrophic Scars Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Hypertrophic Scars Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hypertrophic Scars Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Hypertrophic Scars Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Hypertrophic Scars Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hypertrophic Scars Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Hypertrophic Scars Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hypertrophic Scars Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hypertrophic Scars Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Galena Biopharma, Inc., 2014* 32
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Medical Research, Inc., 2014* 34
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by MS Clinical Research Pvt Ltd, 2014* 35
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2014* 36
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014* 37
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 38
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2014* 39
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014* 40
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 41
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 42
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 43
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by Association of Dutch Burn Centres, 2014* 44
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 45
Hypertrophic Scars Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 46

List of Figures
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hypertrophic Scars Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypertrophic Scars Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypertrophic Scars Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hypertrophic Scars Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hypertrophic Scars Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Hypertrophic Scars to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Hypertrophic Scars Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypertrophic Scars Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypertrophic Scars to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Hypertrophic Scars Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Hypertrophic Scars Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hypertrophic Scars Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Hypertrophic Scars Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hypertrophic Scars Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Hypertrophic Scars Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hypertrophic Scars Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hypertrophic Scars Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.